Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chih-Hung Hsu

Showing results (1-10 of 242) with videos related to

Pageof 25
Sort By:
Advances in Experimental Medicine and Biology|June 16, 2007
Clinical studies with curcuminChih-Hung Hsu, Ann-Lii Cheng
Annals of Translational Medicine|January 5, 2018
On predicting clinical response to chemoradiotherapy in esophageal squamous cell carcinoma: additional evaluation by magnetic resonance imaging may helpTa-Chen Huang, Chih-Hung Hsu
Materials (Basel, Switzerland)|August 10, 2017
Effect of the Cu Source on Optical Properties of CuZnO Films Deposited by Ultrasonic SprayingChih-Hung Hsu, Lung-Chien Chen, Xiuyu Zhang
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 1, 2019
Anti-PD-1 immunotherapy in advanced esophageal squamous cell carcinoma: A long-awaited breakthrough finally arrivesHung-Yang Kuo, Jhe-Cyuan Guo, Chih-Hung Hsu
Journal of the Formosan Medical Association = Taiwan Yi Zhi|June 9, 2022
Embracing anti-PD-1 immunotherapy in the treatment of esophageal cancer: Implications of positive phase III trials in advanced and resected esophageal cancerHung-Yang Kuo, Jhe-Cyuan Guo, Chih-Hung Hsu
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 15, 2020
It takes two to tango: breakthrough advanced hepatocellular carcinoma treatment that combines anti-angiogenesis and immune checkpoint blockadeTsung-Hao Liu, Yu-Yun Shao, Chih-Hung Hsu
Anticancer Research|August 5, 2006
Complete response of urothelial carcinoma to chemotherapy in renal allograft recipients: a two-case studyChia-Chi Lin, Chih-Hung Hsu, Yeong-Shiau Pu
The Oncologist|March 9, 2021
An Underdiagnosed Hypothyroidism and Its Clinical Significance in Patients with Advanced Hepatocellular CarcinomaYu-Yun Shao, Ann-Lii Cheng, Chih-Hung Hsu
Liver Cancer|October 26, 2013
Predictive biomarkers of antiangiogenic therapy for advanced hepatocellular carcinoma: where are we?Yu-Yun Shao, Chih-Hung Hsu, Ann-Lii Cheng
Journal of Hepatocellular Carcinoma|May 25, 2019
Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectivesLi-Chun Lu, Chun-Jung Chang, Chih-Hung Hsu
Pageof 25

Showing results (1-10 of 242) with videos related to

Sort By:
Pageof 25
Advances in Experimental Medicine and Biology|June 16, 2007
Clinical studies with curcuminChih-Hung Hsu, Ann-Lii Cheng
Annals of Translational Medicine|January 5, 2018
On predicting clinical response to chemoradiotherapy in esophageal squamous cell carcinoma: additional evaluation by magnetic resonance imaging may helpTa-Chen Huang, Chih-Hung Hsu
Materials (Basel, Switzerland)|August 10, 2017
Effect of the Cu Source on Optical Properties of CuZnO Films Deposited by Ultrasonic SprayingChih-Hung Hsu, Lung-Chien Chen, Xiuyu Zhang
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 1, 2019
Anti-PD-1 immunotherapy in advanced esophageal squamous cell carcinoma: A long-awaited breakthrough finally arrivesHung-Yang Kuo, Jhe-Cyuan Guo, Chih-Hung Hsu
Journal of the Formosan Medical Association = Taiwan Yi Zhi|June 9, 2022
Embracing anti-PD-1 immunotherapy in the treatment of esophageal cancer: Implications of positive phase III trials in advanced and resected esophageal cancerHung-Yang Kuo, Jhe-Cyuan Guo, Chih-Hung Hsu
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 15, 2020
It takes two to tango: breakthrough advanced hepatocellular carcinoma treatment that combines anti-angiogenesis and immune checkpoint blockadeTsung-Hao Liu, Yu-Yun Shao, Chih-Hung Hsu
Anticancer Research|August 5, 2006
Complete response of urothelial carcinoma to chemotherapy in renal allograft recipients: a two-case studyChia-Chi Lin, Chih-Hung Hsu, Yeong-Shiau Pu
The Oncologist|March 9, 2021
An Underdiagnosed Hypothyroidism and Its Clinical Significance in Patients with Advanced Hepatocellular CarcinomaYu-Yun Shao, Ann-Lii Cheng, Chih-Hung Hsu
Liver Cancer|October 26, 2013
Predictive biomarkers of antiangiogenic therapy for advanced hepatocellular carcinoma: where are we?Yu-Yun Shao, Chih-Hung Hsu, Ann-Lii Cheng
Journal of Hepatocellular Carcinoma|May 25, 2019
Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectivesLi-Chun Lu, Chun-Jung Chang, Chih-Hung Hsu
Pageof 25